S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69

U.S. Physical Therapy Stock Forecast, Price & News

+1.74 (+1.92%)
(As of 01/21/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
121,780 shs
Average Volume
87,706 shs
Market Capitalization
$1.19 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive USPH News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

U.S. Physical Therapy logo

About U.S. Physical Therapy

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, which provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The company operates through the following segments: physical therapy operations and industrial injury prevention services. The physical therapy operations segment consist of physical therapy and occupational therapy clinics that provide pre-and postoperative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The injury prevention services segment includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. U.S. Physical Therapy was founded in 1990 and is headquartered in Houston, TX.


U.S. Physical Therapy (NYSE:USPH) Stock Price Up 4.2%
January 13, 2022 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Health services
Health Care Facilities
Year Founded

Sales & Book Value

Annual Sales
$422.97 million
Cash Flow
$3.70 per share
Book Value
$21.60 per share


Net Income
$35.19 million
Pretax Margin




Free Float
Market Cap
$1.19 billion

Company Calendar

Last Earnings
Ex-Dividend for 12/10 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End


Overall MarketRank

2.93 out of 5 stars

Medical Sector

26th out of 1,418 stocks

Health Services Industry

1st out of 17 stocks

Analyst Opinion: 3.5Community Rank: 3.9Dividend Strength: 4.2Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -

U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

Is U.S. Physical Therapy a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" U.S. Physical Therapy stock.
View analyst ratings for U.S. Physical Therapy
or view top-rated stocks.

How has U.S. Physical Therapy's stock price been impacted by Coronavirus (COVID-19)?

U.S. Physical Therapy's stock was trading at $93.22 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, USPH shares have decreased by 0.8% and is now trading at $92.50.
View which stocks have been most impacted by COVID-19

When is U.S. Physical Therapy's next earnings date?

U.S. Physical Therapy is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for U.S. Physical Therapy

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) released its quarterly earnings results on Thursday, November, 4th. The company reported $0.85 EPS for the quarter, beating the Zacks' consensus estimate of $0.78 by $0.07. The firm had revenue of $125.90 million for the quarter, compared to analyst estimates of $124.67 million. U.S. Physical Therapy had a trailing twelve-month return on equity of 16.63% and a net margin of 6.64%. The firm's revenue for the quarter was up 15.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.86 earnings per share.
View U.S. Physical Therapy's earnings history

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy declared a quarterly dividend on Tuesday, November 2nd. Investors of record on Monday, November 15th will be given a dividend of $0.38 per share on Friday, December 10th. This represents a $1.52 annualized dividend and a dividend yield of 1.64%. The ex-dividend date of this dividend is Friday, November 12th.
View U.S. Physical Therapy's dividend history

Is U.S. Physical Therapy a good dividend stock?

U.S. Physical Therapy pays an annual dividend of $1.52 per share and currently has a dividend yield of 1.67%. U.S. Physical Therapy has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of U.S. Physical Therapy is 64.14%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 45.65% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend.
View U.S. Physical Therapy's dividend history.

What price target have analysts set for USPH?

4 analysts have issued 12-month price objectives for U.S. Physical Therapy's stock. Their forecasts range from $120.00 to $139.00. On average, they anticipate U.S. Physical Therapy's stock price to reach $131.33 in the next year. This suggests a possible upside of 42.0% from the stock's current price.
View analysts' price targets for U.S. Physical Therapy
or view top-rated stocks among Wall Street analysts.

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the following people:

What is Chris Reading's approval rating as U.S. Physical Therapy's CEO?

38 employees have rated U.S. Physical Therapy CEO Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among U.S. Physical Therapy's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Boston Trust Walden Corp (3.38%), Copeland Capital Management LLC (3.22%), Riverbridge Partners LLC (2.95%), Fenimore Asset Management Inc. (0.82%), Scout Investments Inc. (0.70%) and Russell Investments Group Ltd. (0.24%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Christopher J Reading, Edward L Kuntz, Glenn Mcdowell, Graham D Reeve, Graham D Reeve, Harry S Chapman, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson.
View institutional ownership trends for U.S. Physical Therapy

Which institutional investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, Scout Investments Inc., and State of Alaska Department of Revenue. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Christopher J Reading, Edward L Kuntz, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Lawrance W Mcafee, and Mark J Brookner.
View insider buying and selling activity for U.S. Physical Therapy
or view top insider-selling stocks.

Which institutional investors are buying U.S. Physical Therapy stock?

USPH stock was bought by a variety of institutional investors in the last quarter, including Copeland Capital Management LLC, Riverbridge Partners LLC, Russell Investments Group Ltd., Fenimore Asset Management Inc., and Precision Wealth Strategies LLC. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin, and Regg E Swanson.
View insider buying and selling activity for U.S. Physical Therapy
or or view top insider-buying stocks.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $92.50.

How much money does U.S. Physical Therapy make?

U.S. Physical Therapy has a market capitalization of $1.19 billion and generates $422.97 million in revenue each year. The company earns $35.19 million in net income (profit) each year or $2.37 on an earnings per share basis.

How many employees does U.S. Physical Therapy have?

U.S. Physical Therapy employs 4,630 workers across the globe.

What is U.S. Physical Therapy's official website?

The official website for U.S. Physical Therapy is www.usph.com.

Where are U.S. Physical Therapy's headquarters?

U.S. Physical Therapy is headquartered at 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at (713) 297-7000, via email at [email protected], or via fax at 713-297-7090.

This page was last updated on 1/23/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.